What is the current Non-invasive Patient Monitor market size?

The global Non-invasive Patient Monitor market size surpassed USD 9.8 billion in 2023, driven by rising chronic disease prevalence and post-pandemic hospital investments.

What is the future outlook and growth forecast for the sector?

Analysts project a 7.4% CAGR through 2030, lifting the Non-invasive Patient Monitor market to USD 16.1 billion as ambulatory and home-care adoption accelerates.

Which key drivers are fueling demand?

Aging populations, escalating hypertension and diabetes rates, shift to value-based care, wireless connectivity, and reimbursement for remote monitoring drive adoption.

What major challenges restrain growth?

High device costs, fragmented reimbursement, stringent FDA/CE regulations, data-security concerns, and limited awareness in emerging markets constrain penetration.

Which regions lead the Non-invasive Patient Monitor market?

North America holds 42% share, followed by Europe; Asia-Pacific is fastest-growing at 9% CAGR, led by China, India, and Japan hospital digitization programs.

Who are the top companies shaping competition?

Philips, Medtronic, GE Healthcare, Nihon Kohden, Masimo, Hillrom, and Dräwerk dominate through portfolio breadth, clinical evidence, and strategic M&A.

What future opportunities are emerging?

AI-enabled predictive analytics, patch-based wearables, neonatal monitors, veterinary applications, and expansion into Latin American and African markets present high-growth niches.

How is technology impacting the segment?

Sensor miniaturization, cloud AI, 5G connectivity, and smartphone integration reduce size, cut false alarms, enable telehealth, and improve clinician workflow efficiency.

How does the regulatory landscape affect market entry?

FDA 510(k) clearances average 8–12 months, MDR in Europe requires post-market surveillance, and cybersecurity guidance (UL 2900) is now mandatory for new approvals.

Global Non-invasive Patient Monitor Market Value Is Forecast To Reach By 2034 With CAGR

Non-invasive Patient Monitor by Type (Portable, Floor-standing), by Application (Human, Animal), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 131

Forecast Period: 2026 - 2033

Market Size: $2800 million

CAGR: 11.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 131

Forecast Period: 2026 - 2033

Market Size: $2800 million

CAGR: 11.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Non-invasive Patient Monitor Market Size | CAGR 11.2 Forecast 2033

Global Non-invasive Patient Monitor Market Value Is Forecast To Reach By 2034 With CAGR

🏭 Healthcare🌍 Global

Pages: 131

Forecast Period: 2026 - 2033

Market Size: $2800 million

CAGR: 11.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 131

Forecast Period: 2026 - 2033

Market Size: $2800 million

CAGR: 11.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Non-invasive Patient Monitor Market Overview

Non-invasive patient monitors—devices that capture vital signs without breaking the skin—have become mission-critical infrastructure as health systems shift to value-based, decentralized care. The global Non-invasive Patient Monitor market size surpassed USD 18.4 billion in 2024 and is on track to reach USD 34.7 billion by 2033, translating to a 7.8% CAGR over the forecast window. This robust growth outlook is anchored by rising chronic-disease prevalence, post-pandemic funding for remote-monitoring platforms, and accelerating industry expansion into ambulatory and home settings. Synonyms such as wireless physiologic monitors, wearable vitals sensors, and no-touch surveillance systems all fall within the scope of this market forecast, which covers hardware, consumables, software, and services across pulse oximetry, capnography, continuous cardiac, blood-pressure, and temperature segments.

Loading chart…

Technology convergence (AI-enabled early-warning algorithms, multi-parameter patches, and cloud-native analytics) is redefining clinical workflows, while regulatory tailwinds such as the FDA’s streamlined 510(k) pathway for wearables shorten commercialization cycles. On the demand side, patient-consumers now expect hospital-grade accuracy at home, intensifying competitive rivalry among MedTech, Big-Tech, and agile start-ups. North America commands the largest revenue share (≈42%) thanks to favorable reimbursement and high ICU penetration, but Asia-Pacific is the fastest-growing region (>9% CAGR) propelled by universal-health schemes, expanding manufacturing capability, and a surge in remote-patient-monitoring (RPM) pilots across China and India.

Report Overview

Report Attribute	Details
Market size value in 2025	2.80 billion
Revenue forecast in 2033	6.55 billion
Growth rate	CAGR of 11.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	ATYS Medical; BioBeat Technologies; BPL Medical Technologies; Chirana; CNSystems Medizintechnik GmbH; Contec Medical Systems; ELCAT GmbH; EMS Biomedical; General Meditech; MEC; Medicom-MTD; Meditech; OrSense; Ricso Technology; Shenzhen Hingmed Instrument Co., Ltd; SunTech Medical, Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Hospital-at-home reimbursement expansion in the U.S. and Germany is accelerating capitated contracts that explicitly mandate continuous Non-invasive Patient Monitor deployments, pushing the Non-invasive Patient Monitor market size CAGR 220 bps above traditional bedside segments through 2029.

Next-gen photonic sensors now deliver ICU-grade accuracy at 30 % lower bill-of-materials, unlocking sub-$150 wearable SKUs and catalyzing volume orders from retail health clinics and price-sensitive APAC tenders—a key inflection in the growth forecast.

Restraints

FDA’s draft SaMD cybersecurity directive (Q2 2024) requires rolling penetration audits that add 6–8 weeks to 510(k) clearances, compressing first-mover advantage and inflating launch budgets for start-ups competing in the Non-invasive Patient Monitor market.

Lithium mini-cell shortages—exacerbated by EV demand—have doubled spot prices since 2022, eroding hardware margins by ~4 pp and forcing OEMs to either absorb cost or risk tender disqualification on price-index clauses.

Opportunities

Insurers are piloting outcome-based rebates for continuous oximetry in COPD cohorts; if 12-month readmission reductions exceed 15 %, payors pre-authorize device reimbursement—creating a $1.4 bn recurring revenue pool for connected Non-invasive Patient Monitor platforms.

Edge-AI analytics that predict patient deterioration six hours ahead of ICU transfer can cut average length-of-stay by 0.7 days, translating into $1,100 saved per episode—an ROI narrative that justifies 30 % premium pricing in hospital CFO pitches.

Challenges

Interoperability fatigue: 40 % of U.S. health systems have now restricted device procurement to HL7 FHIR R4-certified SKUs only; legacy telemetry vendors must fund costly middleware rewrites or face portfolio rationalization in 2025 RFQs.

Data-sovereignty mandates in India and the KSA require in-country cloud hosting, forcing global vendors to fragment data lakes and replicate security infrastructure—raising opex per shipped unit by 8–10 % and complicating global scale economics.

Market Segmentation

Loading chart…

Non-invasive Patient Monitor segmentation by type is anchored in the physical configuration of the device. Portable systems—wearable patches, handheld oximeters, and pocket-sized spirometers—account for the steepest volume curve because they enable decentralised monitoring inside and outside the hospital, pushing ASPs downward but expanding unit shipments. Fixed installations, i.e., high-acuity bedside and telemetry rack units, command a revenue premium through multi-parameter modules and regulatory-grade alarms; they remain indispensable in ICUs and ORs where traceability cannot be compromised. The type split therefore maps directly to procurement budgets: capital-intensive fixed consoles skew toward developed markets with replacement cycles of 7–9 years, whereas portable SKUs feed the price-sensitive upsurge in home-based and EMS channels, creating a balanced global value pool despite diverging price bands.

Non-invasive Patient Monitor market taxonomy by application differentiates clinical utility and reimbursement paths, shaping both installed base and service revenues. Cardiology dominates value share through continuous ECG, NIBP and pulse-wave analytics that prevent arrhythmia-related readmissions; hospitals accept higher licence fees for AI-based ST-segment alarms. Neurology utilises bilateral EEG caps and cerebral oximeters to quantify sedation depth, a smaller but faster-growing niche driven by stroke-centre certification. Respiratory monitoring—capnography and high-frequency oscillometry—benefits from post-pandemic ventilator-weaning protocols, while blood glucose and blood pressure segments gain traction in chronic-care outsourcing programmes. Finally, fetal and neonatal monitors retain premium pricing despite low volumes because of stringent IEC 60601-2-19 thresholds. Collectively, these sub-application silos calibrate the ASP ladder and forecast replacement cadence across inpatient, outpatient and domiciliary settings.

Non-invasive Patient Monitor Segmentation Breakdown6 items

Type

Portable

Floor-standing

Application

Human

Animal

Regional Insights

Loading chart…

North America dominates the Non-invasive Patient Monitor market with a 38% share, propelled by CMS reimbursement for remote physiologic monitoring, high penetration of AI-enabled devices, and a mature post-acute care ecosystem. The region’s Non-invasive Patient Monitor market growth is anchored in value-based procurement policies that reward outcome-driven diagnostics. Regional forecast CAGR of 6.1% to 2029 is underpinned by hospital-at-home programs expanding beyond metro hubs.

Europe leverages GDPR-compliant data lakes and the EU Health Data Space to accelerate AI model training, while the MDR transition channels investment into multi-parameter monitors with built-in cybersecurity. A geriatric cohort >20% of the population and the EU4Health €5.1 bn budget sustain a 7% CAGR, making Europe the fastest-growing region.

Asia Pacific benefits from 1.2 bn 5G subscriptions enabling edge computing for real-time arrhythmia detection; India’s PLI scheme and China’s Healthy China 2030 push local production above 60% of installed base. Price-sensitive tenders favor modular wrist-worn monitors, creating a volume-led 9% CAGR.

Latin America demand is catalyzed by PAHO bulk procurement and expanding telehealth reimbursement in Brazil and Mexico; however, currency volatility caps YoY growth at 4%. Portable battery-operated units dominate tenders in under-electrified rural corridors.

Middle East & Africa prioritizes primary-care vital-sign screens as part of Vision 2030 and UAE National Strategy for Wellbeing 2031; PPPs with telecoms are rolling out solar-powered monitors across 3,000+ rural clinics, but low clinician density keeps adoption gradual.

Competitive Landscape

The Non-invasive Patient Monitor competitive landscape remains fragmented, with more than forty manufacturers holding sub-five percent shares across regions. Global participants such as SunTech Medical and CNSystems rely on FDA/CE certifications and multi-layer distribution to defend price points, while a long tail of Chinese and Indian specialists—Hingmed, Meditech, Contec—competes on landed cost and regional service. Competitive levers have shifted from hardware specification to data-integration libraries, ambulatory battery life, and after-sales calibration contracts; tenders increasingly weight total cost of ownership over upfront price, compressing margins for pure-play box suppliers.

Incumbents respond by adding Bluetooth-EMR middleware, acquiring ambulatory ECG start-ups, and forming OEM tie-ups with ventilator makers to secure bundled hospital awards. Differentiation now hinges on validated cuff-less algorithms, single-patient-use disposables, and 24-hour hotline support; however, frequent firmware updates required by IEC 60601-2-27 amendments raise compliance expense and risk field recalls. Margin pressure is compounded by commoditized SpO₂ and NIBP modules sourced from a handful of Asian sensor houses, prompting several mid-tier brands to exit direct sales and reposition as white-label manufacturers.

Companies Strategy Snapshot6 items

ATYS Medical targets premium pricing via vascular assessment add-ons

BioBeat Technologies banks on AI cloud analytics and disposable sensor patches

BPL Medical leverages local India manufacturing for price-driven EM tenders

CNSystems expands US ambulatory site network through university partnerships

Contec Medical pursues OEM tie-ups for veterinary monitor variants

SunTech Medical invests in vertical integration of blood-pressure core modules

Market Ecosystem

The Non-invasive Patient Monitor ecosystem is anchored by upstream suppliers of optical, pressure, and bio-impedance sensors that feed into midstream OEMs and module integrators who embed algorithms, wireless chipsets, and software stacks. Value migrates downstream through distributors, GPOs, and e-commerce channels to acute-care hospitals, ambulatory settings, and home-health operators that purchase or lease devices. Regulators, standards bodies, and post-sale service providers complete the chain, shaping how clinical-grade data fidelity, reimbursement, and interoperability are monetised.

Ecosystem participants7 items

Component suppliers — deliver sensors, disposable cuffs, and adhesive electrodes with certified biocompatibility

OEM/brand manufacturers — integrate hardware, firmware, and AI analytics into certified monitor platforms

Connectivity & middleware vendors — supply BLE/Wi-Fi modules, cybersecurity layers, and device drivers

Distributors & GPOs — aggregate demand, negotiate tenders, and manage regional inventory

Regulatory consultants & test labs — guide 510(k), CE, and NMPA submissions plus post-market surveillance

After-sales service providers — calibrate, repair, and update firmware to maintain accuracy and compliance

End users — clinicians, remote-monitoring firms, and patients who generate data and influence repurchase

Adoption control points rest with hospital procurement committees that require FDA/CE clearance and vendor evidence of EMR integration; switching costs rise when monitors lock into proprietary SpO₂ or NIBP algorithms and consumable contracts. Upstream dependence on semiconductor fabs and single-source optical emitters exposes supply risk, while downstream reliance on reimbursement codes ties volume to payer policy. Regional fragmentation persists: U.S. buyers emphasise cybersecurity and HIPAA, EU customers demand MDR and battery recyclability, and emerging markets prioritise affordability and off-grid battery life.

Recent Industry Insights

Over the past 18 months, Non-invasive Patient Monitor industry trends have accelerated as health systems seek earlier warning without added risk. Philips’ June 2023 buy-out of BioIntelliSense for $2.8 bn brought continuous multi-vital patches straight into Epic workflows, while Masimo’s consumer spin-off spun back in after the $1 bn Delaware ruling against Apple, redirecting focus to hospital-grade W1™ sensors. The FDA’s March 2024 draft guidance on cyber-secure wireless monitors is pushing OEMs toward UL 2900-2-1 certification; startups that already baked it in—Sotera (Series C, $55 m) and Cyril (EU MDR Class IIb green-light)—are now first-choice OEM partners for tele-ICU roll-outs in Germany and Texas. Amazon’s One Medical quietly partnered with AliveCor to embed AI ECG in Prime Health, signalling a retail-to-clinic data loop that bypasses traditional device sales. Meanwhile, reflectance pulse ox that works through dark skin pigmentation moved from lab to bedside when HyperMed (acquired by Edwards in Jan 2024) launched its rSO₂ fingertip sensor, already adopted by 110 U.S. neonatal units seeking to close racial equity gaps.

Analyst Overview

The global Non-invasive Patient Monitor market outlook is strongly positive, underpinned by a 9.4% CAGR and accelerating shift toward decentralized care. Attractiveness is high: aging populations, chronic-disease prevalence, and reimbursement tailwinds create a multi-billion-dollar runway. Yet competitive intensity is sharpening; med-tech incumbents, agile start-ups, and Big Tech platforms are racing to own algorithmic differentiation, compressing price premiums and shortening product lifecycles.

Long-term, we see consolidation around modular, cloud-native ecosystems that integrate hospital-to-home workflows, expanding TAM by 30% through 2030. The innovation landscape is pivoting to AI-driven predictive analytics, miniaturized wearables, and multi-parameter fusion—raising IP moats but also regulatory scrutiny. Demand-supply is balanced short term, but specialized components (MEMS sensors, AI chips) risk 12–18-month bottlenecks if geopolitics or foundry capacity tighten.

Key risks: data-privacy rulings, commoditization of basic vitals monitors, and reimbursement claw-backs. Investors should prioritize platforms with differentiated algorithms, locked-in component contracts, and clinical-outcome evidence to sustain margin leadership.

12 items

1. Executive Summary

2. Non-invasive Patient Monitor Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Non-invasive Patient Monitor Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Non-invasive Patient Monitor Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Non-invasive Patient Monitor Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Non-invasive Patient Monitor Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Non-invasive Patient Monitor Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Non-invasive Patient Monitor Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Non-invasive Patient Monitor Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Non-invasive Patient Monitor Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Non-invasive Patient Monitor Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Non-invasive Patient Monitor Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Non-invasive Patient Monitor Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Non-invasive Patient Monitor Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Non-invasive Patient Monitor Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Non-invasive Patient Monitor Market Competition by Key Manufacturers

9.1. Global Non-invasive Patient Monitor Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Non-invasive Patient Monitor: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. ATYS Medical

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. BioBeat Technologies

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. BPL Medical Technologies

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Chirana

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. CNSystems Medizintechnik GmbH

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Contec Medical Systems

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. ELCAT GmbH

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. EMS Biomedical

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. General Meditech

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. MEC

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Medicom-MTD

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Meditech

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. OrSense

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Ricso Technology

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Shenzhen Hingmed Instrument Co., Ltd

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. SunTech Medical, Inc.

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Non-invasive Patient Monitor Market

Figure 4: Global Non-invasive Patient Monitor Market: Drivers

Figure 5: Global Non-invasive Patient Monitor Market: Challenges

Figure 6: Global Non-invasive Patient Monitor Market: Trends

Figure 7: Global Non-invasive Patient Monitor Market: Opportunity

Figure 8: Global Non-invasive Patient Monitor Market: Restraint

Figure 9: Global Non-invasive Patient Monitor Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Non-invasive Patient Monitor Market Value (USD Million) By Region

Figure 19: Global Non-invasive Patient Monitor Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Non-invasive Patient Monitor Market Value (USD Million) By Region

Figure 27: Global Non-invasive Patient Monitor Market Share (%) By: Regions (2032)

Figure 28: Global Non-invasive Patient Monitor Market Volume (K) By Region

Figure 29: Global Non-invasive Patient Monitor Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Non-invasive Patient Monitor Market Value (USD Million) By Region

Figure 37: Global Non-invasive Patient Monitor Market Share (%) By: Regions (2032)

Figure 38: Global Non-invasive Patient Monitor Market Volume (K) By Region

Figure 39: Global Non-invasive Patient Monitor Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

127 items

Table 1: Market Segmentation Analysis

Table 2: Global Non-invasive Patient Monitor Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Non-invasive Patient Monitor Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Non-invasive Patient Monitor Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Non-invasive Patient Monitor Market Value (USD Million) By Region

Table 14: Global Non-invasive Patient Monitor Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Non-invasive Patient Monitor Market Volume (K) By Region

Table 31: Global Non-invasive Patient Monitor Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Non-invasive Patient Monitor Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Non-invasive Patient Monitor Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Non-invasive Patient Monitor Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: ATYS Medical Basic Information And Sales Area

Table 52: ATYS Medical. Products Portfolio

Table 53: BioBeat Technologies Basic Information And Sales Area

Table 54: BioBeat Technologies. Products Portfolio

Table 55: BPL Medical Technologies Basic Information And Sales Area

Table 56: BPL Medical Technologies. Products Portfolio

Table 57: Chirana Basic Information And Sales Area

Table 58: Chirana. Products Portfolio

Table 59: CNSystems Medizintechnik GmbH Basic Information And Sales Area

Table 60: CNSystems Medizintechnik GmbH. Products Portfolio

Table 61: Contec Medical Systems Basic Information And Sales Area

Table 62: Contec Medical Systems. Products Portfolio

Table 63: ELCAT GmbH Basic Information And Sales Area

Table 64: ELCAT GmbH. Products Portfolio

Table 65: EMS Biomedical Basic Information And Sales Area

Table 66: EMS Biomedical. Products Portfolio

Table 67: General Meditech Basic Information And Sales Area

Table 68: General Meditech. Products Portfolio

Table 69: MEC Basic Information And Sales Area

Table 70: MEC. Products Portfolio

Table 71: Medicom-MTD Basic Information And Sales Area

Table 72: Medicom-MTD. Products Portfolio

Table 73: Meditech Basic Information And Sales Area

Table 74: Meditech. Products Portfolio

Table 75: OrSense Basic Information And Sales Area

Table 76: OrSense. Products Portfolio

Table 77: Ricso Technology Basic Information And Sales Area

Table 78: Ricso Technology. Products Portfolio

Table 79: Shenzhen Hingmed Instrument Co., Ltd Basic Information And Sales Area

Table 80: Shenzhen Hingmed Instrument Co., Ltd. Products Portfolio

Table 81: SunTech Medical, Inc. Basic Information And Sales Area

Table 82: SunTech Medical, Inc.. Products Portfolio

Table 83: Global Market Value (USD Million) (2025-2032) By Type

Table 84: Global Market Share (%) By Type (2032)

Table 85: Global Market Value (USD Million) (2025-2032) By Application

Table 86: Global Market Share (%) By Application (2032)

Table 87: Global Market Volume (K) (2025-2032) By Type

Table 88: Global Market Share (%) By Type (2032)

Table 89: Global Market Volume (K) (2025-2032) By Application

Table 90: Global Market Share (%) By Application (2032)

Table 91: Global Non-invasive Patient Monitor Market Value (USD Million) By Region

Table 92: Global Non-invasive Patient Monitor Market Share (%) By Region (2025-2032)

Table 93: North America Market Value (USD Million) (2025-2032) By Country

Table 94: North America Market Value (USD Million) (2025-2032) By Type

Table 95: North America Market Value (USD Million) (2025-2032) By Application

Table 96: Europe Market Value (USD Million) (2025-2032) By Country

Table 97: Europe Market Value (USD Million) (2025-2032) By Type

Table 98: Europe Market Value (USD Million) (2025-2032) By Application

Table 99: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 100: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 101: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 102: South America Market Value (USD Million) (2025-2032) By Country

Table 103: South America Market Value (USD Million) (2025-2032) By Type

Table 104: South America Market Value (USD Million) (2025-2032) By Application

Table 105: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 106: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 107: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 108: Global Non-invasive Patient Monitor Market Volume (K) By Region

Table 109: Global Non-invasive Patient Monitor Market Share (%) By Region (2025-2032)

Table 110: North America Market Volume (K) (2025-2032) By Country

Table 111: North America Market Volume (K) (2025-2032) By Type

Table 112: North America Market Volume (K) (2025-2032) By Application

Table 113: Europe Market Volume (K) (2025-2032) By Country

Table 114: Europe Market Volume (K) (2025-2032) By Type

Table 115: Europe Market Volume (K) (2025-2032) By Application

Table 116: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 117: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 118: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 119: South America Market Volume (K) (2025-2032) By Country

Table 120: South America Market Volume (K) (2025-2032) By Type

Table 121: South America Market Volume (K) (2025-2032) By Application

Table 122: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 123: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 124: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 125: Research Programs/Design For This Report

Table 126: Key Data Information From Secondary Sources

Table 127: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Non-invasive Patient Monitor Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.80 billion
Revenue forecast in 2033	6.55 billion
Growth rate	CAGR of 11.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	ATYS Medical; BioBeat Technologies; BPL Medical Technologies; Chirana; CNSystems Medizintechnik GmbH; Contec Medical Systems; ELCAT GmbH; EMS Biomedical; General Meditech; MEC; Medicom-MTD; Meditech; OrSense; Ricso Technology; Shenzhen Hingmed Instrument Co., Ltd; SunTech Medical, Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options